Dr Joanna Leaviss

All publications

Journal articles

• Leaviss J, Carroll C, Essat M, van der Windt D, Grainge MJ, Card T, Riley R & Abhishek A (2024) Prognostic factors for liver, blood and kidney adverse events from glucocorticoid sparing immune-suppressing drugs in immune-mediated inflammatory diseases: a prognostic systematic review. RMD Open, 10(1). View this article in WRRO
• Scope A, Leaviss J, Booth A, Sutton A, Parry G, Buszewicz M & Moss-Morris R (2021) The acceptability of primary care or community-based behavioural interventions for persistent physical symptoms: Qualitative systematic review.. Br J Health Psychol, 26(4), 1069-1094. View this article in WRRO
• Carlton J, Leaviss J, Pouwer F, Hendrieckx C, Broadley MM, Clowes M, McCrimmon RJ, Heller SR & Speight J (2021) The suitability of patient-reported outcome measures used to assess the impact of hypoglycaemia on quality of life in people with diabetes: a systematic review using COSMIN methods.. Diabetologia, 64(6), 1213-1225. View this article in WRRO
• Thomas C, Brennan A, Goka E, Squires HY, Brenner G, Bagguley D, Buckley Woods H, Gillett M, Leaviss J, Clowes M , Heathcote L et al (2020) What are the cost-savings and health benefits of improving detection and management for six high cardiovascular risk conditions in England? An economic evaluation.. BMJ Open, 10(9), e037486. View this article in WRRO
• Leaviss J, Davis S, Ren S, Hamilton J, Scope A, Booth A, Sutton A, Parry G, Buszewicz M, Moss-Morris R & White P (2020) Behavioural modification interventions for medically unexplained symptoms in primary care: systematic reviews and economic evaluation.. Health Technol Assess, 24(46), 1-490. View this article in WRRO
• Bessey A, Chilcott J, Leaviss J, de la Cruz C & Wong R (2019) A cost-effectiveness analysis of newborn screening for severe combined immunodeficiency in the UK. International Journal of Neonatal Screening, 5(3). View this article in WRRO
• Bessey A, Chilcott JB, Leaviss J & Sutton A (2018) Economic impact of screening for X-linked Adrenoleukodystrophy within a newborn blood spot screening programme.. Orphanet J Rare Dis, 13(1), 179-179. View this article in WRRO
• Sutton AJ, Galvan De La Cruz MC, Leaviss J & Booth A (2017) Searching for trial protocols: A comparison of methods. Research Synthesis Methods. View this article in WRRO
• Sutton A, de la Cruz MDCG, Booth A & Leaviss J (2017) VP198 Efficient Retrieval Of Trial Protocols: An Empirical Study. International Journal of Technology Assessment in Health Care, 33(S1), 242-242. View this article in WRRO
• Kearns B, Rafia R, Leaviss J, Preston L, Brazier JE, Palmer S & Ara R (2017) The cost-effectiveness of changes to the care pathway used to identify depression and provide treatment amongst people with diabetes in England: a model-based economic evaluation. BMC Health Services Research, 17(1), 78-78. View this article in WRRO
• Sammy IA, Lecky FE, Sutton A, Leaviss J & O'Cathain A (2016) Factors affecting mortality in older trauma patients—A systematic review and meta-analysis. Injury, 47(6), 1170-1183. View this article in WRRO
• Leaviss J & Uttley L (2015) Psychotherapeutic benefits of compassion-focused therapy: an early systematic review. Psychological Medicine, 45(05), 927-945. View this article in WRRO
• Carroll C, Hummel S, Leaviss J, Ren S, Stevens JW, Cantrell A & Michaels J (2014) Systematic review, network meta-analysis and exploratory cost-effectiveness model of randomized trials of minimally invasive techniques versus surgery for varicose veins.. Br J Surg, 101(9), 1040-1052. View this article in WRRO
• Leaviss J, Hummel S, Carroll C, Ren S, Stevens JW, Everson-Hock E, Cantrell A, Stevenson M & Michaels J (2014) Clinical and cost-effectiveness of minimally invasive techniques for the treatment of varicosis: Systematic review and economic evaluation. Vasomed, 26(4), 210-211.
• Leaviss J, Sullivan W, Ren S, Everson-Hock E, Stevenson M, Stevens JW, Strong M & Cantrell A (2014) What is the clinical effectiveness and cost-effectiveness of cytisine compared with varenicline for smoking cessation? A systematic review and economic evaluation.. Health Technol Assess, 18(33), 1-120.
• Fishwick D, Carroll C, McGregor M, Drury M, Webster J, Bradshaw L, Rick J & Leaviss J (2013) Smoking cessation in the workplace.. Occup Med (Lond), 63(8), 526-536.
• Scope A, Leaviss J, Kaltenthaler E, Parry G, Sutcliffe P, Bradburn M & Cantrell A (2013) Is group cognitive behaviour therapy for postnatal depression evidence-based practice? A systematic review.. BMC Psychiatry, 13, 321. View this article in WRRO
• Carroll C, Hummel S, Leaviss J, Ren S, Stevens JW, Everson-Hock E, Cantrell A, Stevenson M & Michaels J (2013) Clinical effectiveness and cost-effectiveness of minimally invasive techniques to manage varicose veins: a systematic review and economic evaluation.. Health Technol Assess, 17(48), i-141.
• Carroll C, Booth A, Leaviss J & Rick J (2013) "Best fit" framework synthesis: refining the method.. BMC Med Res Methodol, 13, 37. View this article in WRRO
• Carroll C, Rick J, Leaviss J, Fishwick D & Booth A (2013) A qualitative evidence synthesis of employees' views of workplace smoking reduction or cessation interventions.. BMC Public Health, 13, 1095. View this article in WRRO
• Goodacre S, Thokala P, Carroll C, Stevens JW, Leaviss J, Al Khalaf M, Collinson P, Morris F, Evans P & Wang J (2013) Systematic review, meta-analysis and economic modelling of diagnostic strategies for suspected acute coronary syndrome.. Health Technol Assess, 17(1), v-188.
• Carroll C, Khalaf MA, Stevens JW, Leaviss J, Goodacre S, Wang J & Collinson PO (2013) Heart-type fatty acid binding protein as an early marker for myocardial infarction: Systematic review and meta-analysis. Emergency Medicine Journal, 30(4), 280-286.
• Leaviss J, Gibb AGF & Bust PD (2008) Ageing workforce in construction - Equipment use and the prevention of early retirement. Contemporary Ergonomics 2008, 221-226.
• McManus IC, Iqbal S, Chandrarajan A, Ferguson E & Leaviss J (2005) Unhappiness and dissatisfaction in doctors cannot be predicted by selectors from medical school application forms: A prospective, longitudinal study. BMC Medical Education, 5.
• Ferguson E, Leaviss J, Townsend E, Fleming P & Lowe KC (2005) Perceived safety of donor blood and blood substitutes for transfusion: The role of informational frame, patient groups and stress appraisals. Transfusion Medicine, 15(5), 401-412.
• Boaden N & Leaviss J (2000) Putting teamwork in context. Medical Education, 34(11), 921-927.
• Leaviss J (2000) Exploring the perceived effect of an undergraduate multiprofessional educational intervention. Medical Education, 34(6), 483-486.
• GOUDIE AJ, LEAVISS J & LEATHLEY MJ (1995) EFFECT OF THE 5-HT3 ANTAGONIST ONDANSETRON ON CHLORDIAZEPOXIDE WITHDRAWAL HYPERTHERMIA. BRITISH JOURNAL OF PHARMACOLOGY, 114, P379-P379.
• Mellor J, Kuznetsov D, Heller S, Gall M-A, Rosilio M, Amiel SA, Ibberson M, McGurnaghan S, Blackbourn L, Berthon W , Salem A et al () Estimating risk of consequences following hypoglycaemia exposure using the Hypo-RESOLVE cohort: a secondary analysis of pooled data from insulin clinical trials. Diabetologia.
• Mellor J, Kuznetsov D, Heller S, Gall M-A, Rosilio M, Amiel SA, Ibberson M, McGurnaghan S, Blackbourn L, Berthon W , Salem A et al () Risk factors and prediction of hypoglycaemia using the Hypo-RESOLVE cohort: a secondary analysis of pooled data from insulin clinical trials. Diabetologia.

Conference proceedings papers

• Sutton A, Scope A, Leaviss J & Booth A (2018) OP105 Systematically Reconstructing Trial Context-Role For CLUSTER Searches?. International Journal of Technology Assessment in Health Care, Vol. 33(S1) (pp 48-49). Cambridge, 17 June 2017 - 21 June 2017. View this article in WRRO
• Bessey A, Leaviss J, de la Cruz GC, Chilcott J & Wong R (2017) THE COST-EFFECTIVENESS OF SCREENING FOR SEVERE COMBINED IMMUNODEFICIENCY (SCID) IN THE UK NHS NEWBORN BLOODSPOT SCREENING PROGRAMME. VALUE IN HEALTH, Vol. 20(9) (pp A501-A501)
• Gibb A, Leaviss J & Bust P (2014) Older construction workers: Needs and abilities. Proceedings 29th Annual Association of Researchers in Construction Management Conference, ARCOM 2013 (pp 261-271)
• Gibb A, Leaviss J & Bust P (2013) Older construction workers: Needs and abilities. Proceedings 29th Annual Association of Researchers in Construction Management Conference, ARCOM 2013 (pp 261-271)
• Carroll C, Goodacre S, Stevens J, Al Khalaf M, Leaviss J, Wang J & Collinson P (2012) DIAGNOSTIC ACCURACY OF EARLY BIOMARKERS FOR ACUTE CORONARY SYNDROME (ACS). VALUE IN HEALTH, Vol. 15(7) (pp A361-A361)

Reports

• Leaviss J, Harnan S, Pandor A & Cantrell A (2022) Newborn screening for congenital adrenal hyperplasia. External review against programme appraisal criteria for the UK National Screening Committee
• Ara R, Duarte A, Harnan S, Leaviss J, Palmer S, Sculpher M & Brazier JE (2015) Supporting the routine collection of patient reported outcome measures in the National Clinical Audits for assessing cost-effectiveness. Work Package 1. What patient reported outcome measures should be used in the 2013/14 National Clinical Audit Programme. Appendix J - Dementia. View this article in WRRO
• Ara R, Duarte A, Harnan S, Leaviss J, Palmer S, Sculpher M & Brazier JE (2015) Supporting the routine collection of patient reported outcome measures in the National Clinical Audits for assessing cost-effectiveness. Work Package 1. What patient reported outcome measures should be used in the 2013/14 National Clinical Audit Programme. Appendix K - Cardiovascular. View this article in WRRO
• Ara R, Duarte A, Harnan S, Leaviss J, Palmer S, Sculpher M & Brazier JE (2015) Supporting the routine collection of patient reported outcome measures in the National Clinical Audits for assessing cost-effectiveness. Work Package 1. What patient reported outcome measures should be used in the 2013/14 National Clinical Audit Programme. Appendix H - Psychological Therapies View this article in WRRO
• Ara R, Duarte A, Harnan S, Leaviss J, Palmer S, Sculpher M & Brazier JE (2015) Supporting the routine collection of patient reported outcome measures in the National Clinical Audits for assessing cost-effectiveness. Work Package 1. What patient reported outcome measures should be used in the 2013/14 National Clinical Audit Programme. Appendix I - Schizophrenia View this article in WRRO
• Ara R, Duarte A, Harnan S, Leaviss J, Palmer S, Sculpher M & Brazier JE (2015) . Supporting the routine collection of patient reported outcome measures in the National Clinical Audits for assessing cost-effectiveness. Work Package 1. What patient reported outcome measures should be used in the 2013/14 National Clinical Audit Programme. Appendix F - Bowel Cancer. View this article in WRRO
• Ara R, Duarte A, Harnan S, Leaviss J, Palmer S, Sculpher M & Brazier JE (2015) Supporting the routine collection of patient reported outcome measures in the National Clinical Audits for assessing cost-effectiveness. Work Package 1. What patient reported outcome measures should be used in the 2013/14 National Clinical Audit Programme. Appendix E - Diabetes View this article in WRRO
• Ara R, Duarte A, Harnan S, Leaviss J, Palmer S, Sculpher M & Brazier JE (2015) Supporting the routine collection of patient reported outcome measures in the National Clinical Audits for assessing cost-effectiveness. Work Package 1. What patient reported outcome measures should be used in the 2013/14 National Clinical Audit Programme. Appendix G - Head and Neck Cancer. View this article in WRRO
• Ara R, Duarte A, Harnan S, Leaviss J, Palmer S, Sculpher M & Brazier JE (2015) Supporting the collection patient reported outcome measures in the National Clinical Audits for assessing costeffectiveness Work Package 1. What patient reported outcome measures should be used in the 13 health conditions specified in the 2013/14 National Clinical Audit programme? APPENDIX C, INFLAMMATORY BOWEL DISEASE View this article in WRRO
• Ara , Duarte A, Harnan S, Leaviss J, Palmer S, Sculpher M & Brazier JE (2015) Supporting the routine collection of patient reported outcome measures in the National Clinical Audits for assessing cost-effectiveness. Work Package 1. What patient reported outcome measures should be used in the 2013/14 National Clinical Audit Programme. Appendix D - Epilepsy View this article in WRRO
• Ara R, Duarte A, Harnan S, Leaviss J, Palmer S, Sculpher M & Brazier JE (2015) Supporting the routine collection of patient reported outcome measures in the National Clinical Audits for assessing cost-effectiveness. Work Package 1. What patient reported outcome measures should be used in the 2013/14 National Clinical Audit Programme. View this article in WRRO
• Kearns B, Rafia R, Leaviss J, Preston L, Wong R, Brazier J, Palmer S & Ara R (2014) Whole pathway modelling of depression in patients. (Theme 2: Mental Health). Part 2. Independent economic evaluation: methods and results, discussion and conclusion
• Kearns B, Rafia R, Leaviss J, Preston L, Wong R, Brazier J, Palmer S & Ara R (2014) Whole pathway modelling of depression in patients. (Theme 2: Mental Health). Appendices.
• Kearns B, Rafia R, Leaviss J, Preston L, Wong R, Brazier J, Palmer S & Ara R (2014) Whole pathway modelling of depression in patients. (Theme 2: Mental Health). Part 1, Executive summary, introduction, clinical reviews and conceptual modelling.

Posters

• Carroll C, Goodacre S, Stevens J & Leaviss J Diagnostic accuracy of early biomarkers for acute coronary syndrome (ACS) (2012).
• Leaviss J, Stevens J, J W, Goodacre S & F M Prognostic accuracy of Exercise ECG and CT Coronary Angiography to predict Major Adverse Cardiac Events (MACE) in patients with suspected Acute Coronary Syndrome (ACS): A systematic review (2012).

Other

• Carlton J, Leaviss J, Pouwer F, Hendrieckx C, Broadley MM, Clowes M, McCrimmon RJ, Heller SR & Speight J (2022) Correction to: The suitability of patient-reported outcome measures used to assess the impact of hypoglycaemia on quality of life in people with diabetes: a systematic review using COSMIN methods.. Diabetologia.